Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Aug 04, 2026
Why Is Aptiv (APTV) Stock Down -15.06% Today?

Why Is Aptiv (APTV) Stock Down -15.06% Today?

Key Takeaways

  • Aptiv shares plunged approximately 15.1% in Tuesday's trading session after the company released its second-quarter 2026 earnings and slashed full-year guidance.
  • The primary catalyst was a significant guidance cut: Aptiv lowered its full-year revenue outlook by $300 million at the midpoint, citing weakening demand in China, production schedule changes, and launch delays.
  • Q2 adjusted EPS of $1.63 beat analyst estimates of $1.42, but the profit beat was completely overshadowed by the downward revision to forward expectations.
  • Q3 guidance came in well below consensus, with revenue projected at $3.12-$3.22 billion versus the $3.30 billion Street estimate and EPS of $1.25-$1.35 versus the $1.60 consensus.
  • China weakness was a recurring theme, with management flagging a 20% year-over-year decline in domestic retail auto sales and reduced export schedules from European luxury OEMs serving the Chinese market.
  • Traders are now watching whether the second-half recovery narrative holds, with Q4 expected to benefit from software revenue timing, volume recovery, and engineering recoveries.

Opening Summary

APTV, the Schaffhausen, Switzerland-based global industrial technology company formerly known as Aptiv PLC, saw its shares tumble roughly 15.1% on Tuesday after the company reported second-quarter 2026 financial results and issued guidance that fell markedly short of Wall Street expectations. The stock dropped from Monday's closing price of $57.23 to approximately $48.61 in intraday trading, as investors focused squarely on a $300 million full-year revenue guidance reduction rather than a quarterly earnings beat. This marks Aptiv's first quarterly report as the reconstituted "New Aptiv" following the April 1 spin-off of its Electrical Distribution Systems segment into Versigent PLC.

Q2 Earnings: The Profit Beat That Couldn't Save the Day

At first glance, Aptiv's second-quarter numbers appeared respectable. The company posted adjusted earnings per share of $1.63, handily surpassing the analyst consensus of $1.42. U.S. GAAP revenue reached $3.3 billion, up 2% year over year on both a reported and adjusted basis. Adjusted EBITDA climbed to $613 million from $547 million a year earlier, with margins expanding to 18.7% from 17.1%. North American revenue surged 10%, and Asia Pacific grew 6%, including 5% growth in China.

Yet beneath the headline beat, cracks were visible. GAAP net income attributable to Aptiv fell to $248 million from $393 million in the prior-year quarter. Free cash flow came in at just $12 million, compared with $219 million in the same period last year. Intelligent Systems revenue was flat year over year at $1.5 billion, while Europe posted an 8% revenue decline. The earnings beat, driven in part by cost discipline rather than robust top-line momentum, did little to reassure investors already on edge about deteriorating macro conditions.

Guidance Cut: The Real Story

The selloff was overwhelmingly driven by the company's sharply reduced forward outlook. Management lowered full-year 2026 revenue guidance to a range of $12.6 billion to $12.8 billion, a $300 million reduction at the midpoint from prior expectations. Adjusted EPS guidance was trimmed to $5.60-$5.80, below the $5.91 consensus, while free cash flow was projected at $625-$725 million.

Third-quarter guidance proved even more disappointing relative to Street forecasts. Aptiv guided for Q3 revenue of $3.12-$3.22 billion and adjusted EPS of $1.25-$1.35, both well below consensus estimates of $3.30 billion and $1.60, respectively. Management attributed the downward revision to three specific factors: approximately $150 million from customer production schedule changes driven primarily by Chinese domestic weakness and European OEM export cuts, roughly $100 million from delayed program launches and production ramps, and about $50 million from enterprise software timing issues.

The second-half growth narrative took a direct hit. While first-half adjusted revenue growth of approximately 1% aligned with prior expectations, second-half growth was slashed from an anticipated 6.5% to just 3%, with production and customer mix headwinds accounting for 2.5 percentage points of that reduction.

China and Global Auto Headwinds

Aptiv's guidance cut underscores a broader deterioration in the global automotive supply chain landscape. The company highlighted that domestic China retail auto sales had fallen approximately 20% year over year, a sharp reversal that caught many suppliers off guard. European luxury automakers, which rely heavily on Chinese export demand, have been scaling back production schedules, directly impacting Aptiv's order book. This China-driven weakness compounds existing pressures from lingering supply chain friction, elevated raw material costs, and an unfavorable customer mix that has disproportionately affected higher-margin product lines.

The challenges are not limited to China. Europe's 8% revenue decline in the quarter reflects sluggish regional auto production, while ongoing tariff uncertainty and elevated interest rates continue to weigh on global vehicle sales. Aptiv's exposure to original equipment manufacturers with concentrated production footprints means that sudden schedule changes at a handful of key customers can rapidly cascade through the company's financial outlook.

Market Context and Trading Activity

Volume in APTV shares was exceptionally heavy on Tuesday, with trading activity surging well above the stock's average daily volume as institutional and retail investors digested the earnings report and guidance revision. The selloff pushed the stock through multiple technical support levels, including its 50-day moving average, and to levels not seen since the depths of its 52-week trading range. The move reflected sector-wide caution rather than broad-market pressure, as major U.S. indices traded modestly higher on the day. Aptiv's decline was company-specific and earnings-driven, not a function of macro risk-off sentiment.

The stock was already under considerable pressure heading into the report. Year-to-date, APTV had declined roughly 25% before Tuesday's plunge, weighed down by post-spin-off uncertainty, weakening EV adoption momentum, and a steady drumbeat of negative analyst revisions. Over the prior 90 days, the company recorded zero positive EPS revisions and 15 negative ones, signaling that Wall Street had been bracing for disappointment — though the magnitude of the guidance cut still caught the market off guard.

What Comes Next for APTV

Aptiv management struck a cautiously optimistic tone about the longer-term picture, emphasizing that the company's $5 billion in quarterly bookings and $10 billion year-to-date keep it on track for a $20 billion annual target. Non-automotive revenue grew 12% in the quarter, with the company advancing from partnerships to commercial-stage activity in robotics and securing a major drone-market contract in early July. The Kyndryl collaboration and the June 2026 NVIDIA partnership on edge AI platforms built on Jetson hardware point to a strategic push beyond traditional automotive markets.

Still, near-term risks remain pronounced. The third quarter is expected to be soft, and the hoped-for Q4 rebound hinges on software revenue recovery, volume normalization, and the typical year-end surge in engineering credits — none of which are guaranteed if macro conditions in China deteriorate further. With 22 of 24 analysts maintaining Buy-equivalent ratings but consensus price targets likely to be revisited downward in the wake of this report, APTV faces a credibility test. Investors will be watching closely to see whether management's second-half recovery narrative materializes or requires yet another reset.

Trending AI Robots

For investors seeking to navigate volatile markets with data-driven discipline, Tickeron offers a comprehensive platform of AI-powered trading bots covering thousands of tickers across diverse strategies and timeframes. Only the strongest performers under current market conditions are featured in the curated Trending AI Robots section, where bots are evaluated by real-time performance metrics, strategy type, and traded symbols. Whether markets are rallying or selling off, these AI-driven tools can help traders identify opportunities and manage risk with systematic, emotion-free execution. Explore the Trending AI Robots page to see which strategies are currently leading the pack.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: APTV

APTV's RSI Oscillator stoops into oversold zone

The RSI Indicator for APTV moved into overbought territory on August 04, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where APTV advanced for three days, in of 273 cases, the price rose further within the following month. The odds of a continued upward trend are .

APTV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on APTV as a result. In of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for APTV turned negative on August 04, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .

The 10-day moving average for APTV crossed bearishly below the 50-day moving average on July 01, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where APTV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for APTV entered a downward trend on August 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. APTV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.154) is normal, around the industry mean (2.949). P/E Ratio (45.019) is within average values for comparable stocks, (71.734). Projected Growth (PEG Ratio) (1.020) is also within normal values, averaging (0.955). APTV has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.025). P/S Ratio (0.615) is also within normal values, averaging (63.703).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. APTV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

Notable companies

The most notable companies in this group are AutoZone (NYSE:AZO), Advance Auto Parts (NYSE:AAP), Goodyear Tire & Rubber Company (The) (NASDAQ:GT).

Industry description

OEM or Original Equipment Manufacturer of auto parts refers to the original producer of a vehicles components, and so OEM car parts are usually identical to the parts used in producing the vehicle in the first place. OEM parts tend to fit the specifications of a particular model, and their compatibility is often guaranteed by the automaker itself. OEM parts could be more expensive to buy (compared to other vendors’ products) when a consumer goes for replacement. However, increased competition from aftermarket parts/third-party vendors could, in some cases, keep EOM prices in check. The industry might progress further in adopting newer technologies like 3D printing to boost supply chain performance and quality. Aptiv PLC, Magna International Inc. and BorgWarner Inc. are major OEMs for autos.

Market Cap

The average market capitalization across the Auto Parts: OEM Industry is 5.41B. The market cap for tickers in the group ranges from 206 to 74.95B. ORLY holds the highest valuation in this group at 74.95B. The lowest valued company is JBZY at 206.

High and low price notable news

The average weekly price growth across all stocks in the Auto Parts: OEM Industry was 1%. For the same Industry, the average monthly price growth was -4%, and the average quarterly price growth was 5%. WKSP experienced the highest price growth at 22%, while MNRO experienced the biggest fall at -24%.

Volume

The average weekly volume growth across all stocks in the Auto Parts: OEM Industry was -16%. For the same stocks of the Industry, the average monthly volume growth was -2% and the average quarterly volume growth was -17%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 45
P/E Growth Rating: 57
Price Growth Rating: 59
SMR Rating: 81
Profit Risk Rating: 87
Seasonality Score: -27 (-100 ... +100)
View a ticker or compare two or three
APTV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of connected technologies and electrical systems for motor vehicles

Industry AutoPartsOEM

Profile
Details
Industry
Auto Parts OEM
Address
5 Hanover Quay
Phone
+353 12597013
Employees
154000
Web
https://www.aptiv.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.